Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 14.84 Net Asset Value | -0.27% 1 Day | +15.85% Year-to-Date | Overall Morningstar Rating |
| Foreign large value Style or Category | No Load Sales Expenses | 0.85% Expense Ratio | Average Morningstar Risk Rating™ |
| 1 month | +2.63% | 3 years | +0.78% | |
| 3 months | +8.32% | 5 years | +8.29% | |
| 1 year | +17.27% | Since inception | +5.24% |
| TRIGX | Category | |
|---|---|---|
| Performance 5-yr return | +8.29% | +7.34% |
| Expense ratio | 0.85% | 1.22% |
| Risk 5 year sharpe ratio | 0.72 | 0.66 |
| Net assets | $13.2B | $1.5B |
| Average market cap | $24.0B | $33.7B |
| Average P/E | 17.4 | 15.7 |
| Portfolio turnover | 37% | 37% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | T. Rowe Price |
| Fund manager & tenure | Jonathan Matthews / 7 Years |
| Minimal initial investment | $2,500.00 |
| Minimum IRA investment | $1,000.00 |
| International stock | 91.93% |
| Cash | 6.72% |
| Fixed income | 1.09% |
| U.S. stock | 0.26% |
| Other | 0.00% |
| Financial service | 24.22% |
| Industrial materials | 22.65% |
| Consumer goods | 13.81% |
| Telecommunication | 9.81% |
| Energy | 9.40% |
| -- | 2.87% |
| -- | 2.18% |
| -- | 1.95% |
| -- | 1.88% |
| GSK GlaxoSmithKline | 1.82% |
| -- | 1.78% |
| -- | 1.44% |
| AZN AstraZeneca | 1.43% |
| -- | 1.43% |
| -- | 1.36% |
